SPATA16 antibody
Principal name
SPATA16 antibody
Alternative names for SPATA16 antibody
Spermatogenesis-associated protein 16, NYD-SP12
SwissProt ID
O94267 (Schpo), P32558 (Yeast), Q0R2U2 (Human), Q8C636 (Mouse), Q8IRG6 (Drome), Q9BXB7 (Human), Q9N5R9 (Caeel)
Ncbi ID
9606, NP_114161, NM_031955, NP_114161.3, NP_081859.1, NM_027583, NM_029150
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of SPATA16 antibody
- Kit Component:
- - KN205462G1, SPATA16 gRNA vector 1 in pCas-Guide vector
- KN205462G2, SPATA16 gRNA vector 2 in pCas-Guide vector
- KN205462D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Dam,A.H., (2007) Am. J. Hum. Genet. 81 (4), 813-820
Human HepG2; WB Suggested Anti-SPATA16 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HepG2 cell lysate; SPATA16 antibody - N-terminal region (ARP58663_P050) in Human HepG2 cells using Western Blot
Predicted band size: 65 kDa . Positive control: Human liver cancer tissue lysate. Recommended dilution: 1/200-1000. (Gel: 12%SDS-PAGE Lysate: 50 ug per lane Primary antibody: 1/200 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 40 seconds)
Predicted cell location: Cytoplasm. Positive control: Human lung cancer tissue. Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human lung cancer tissue using SPATA16 antibody at dilution 1/25, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm. Positive control: Human thyroid and liver cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using SPATA16 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human thyroid and liver cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human liver cancer tissue using SPATA16 antibody at dilution 1/40, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-SPATA16 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: HepG2 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA321912 | SPATA16 antibody |
||||||
| Anti-SPATA16 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA321913 | SPATA16 antibody |
||||||
| Anti-SPATA16 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP760135 | SPATA16 (full length, N-term HIS tag) |
||||
| Recombinant protein of human spermatogenesis associated 16 (SPATA16), full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
 |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY403133 | SPATA16 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR220275L2V | Lenti ORF particles, Spata16 (GFP-tagged) - Mouse spermatogenesis associated 16 (Spata16), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| MR220277L2V | Lenti ORF particles, Spata16 (GFP-tagged) - Mouse spermatogenesis associated 16 (Spata16), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,290.00
|
|
| OriGene Technologies, Inc. | ||
| MR220275L1V | Lenti ORF particles, Spata16 (Myc-DDK-tagged) - Mouse spermatogenesis associated 16 (Spata16), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||
| MR220277L1V | Lenti ORF particles, Spata16 (Myc-DDK-tagged) - Mouse spermatogenesis associated 16 (Spata16), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,160.00
|
|
| OriGene Technologies, Inc. | ||
